SUMMARY Life- 
We,1-2 like others,3-9 have found improved survival in our more recent cohorts of patients undergoing coronary bypass surgery. In order to evaluate the more recent results, we are reporting the estimated survival of various subsets of patients in our experience with this surgery at the Buffalo General Hospital, particularly in the 1051 Received for publication 10 October 1980 tricular resection, internal mammary implants, congenital heart disease, permanent cardiac pacemakers, simultaneous carotid artery surgery, repeat operations, or were done in patients on intra-aortic balloon counterpulsation. These 199 operations were considered complicated, and are excluded from further consideration. The remaining 1269 patients had operations between 1969 and 1977, and included patients in heart failure and patients with poor ventricular function. We have termed them isolated. More than 95 per cent had chest pain, but some had uncontrollable ventricular arrhythmias, and a few had had a recent myocardial infarction but were without symptoms at the time of surgery. Few operations were performed on patients over 70 years of age, or with left ventricular ejection fractions less than 0 30. In the case of repeat coronary bypass surgery the patient was included from the time of the first operation, and followed as if the second had not occurred.
Almost all of the patients were studied by coronary arteriography and left ventriculography at the Buffalo General Hospital by five of us (DTA, ILB, DGG, RNT, JPV). Selective coronary surgery. Almost all studies have included transaxial views."1 12 Ventriculograms were analysed for ejection fraction by a method previously described. 13 A few patients had arteriography in other hospitals. Their films were reviewed at our hospital before surgery, and repeated if unsatisfactory. Vessels were considered significantly diseased and suitable for bypassing if 4 Comparison of survival after operation of patients with one-vessel, two-vessel, three-vessel, and left main disease. None of the differences at any time interval is significant except that survival is better for patients with two-vessel disease than for patients with three-vessel disease at one month, and at two and three years. Moving the division a year later has no important effect on these findings. This difference in survival between the early 218 patients and the later 1051 patients is increasingly significant the longer the patients are followed (Fig. 2) , and at five years is highly significant (p < 0-0001). These results immediately raise the question of possible differences in selection with the passage of time. In only five subsets did the survival of the general public lie more than one standard error of the probability of survival away from the survival of the surgical patients. These patients were 50 to 59 years of age, men and women, with one to three grafts, and those with two-vessel disease. Even so the x2 analysis showed that the differences were not statistically significant at the 5 per cent level. Fig. 3 shows the actuarial survival curves of patients with disease of the left main coronary artery and of patients with three-vessel, two-vessel, and one-vessel disease. In each case the survival of a group of the US population matched for age and sex is also indicated. The survival curve for patients with left main disease runs below that of the general public, but approaches it as time goes on, and is not statistically different at five years. Only 15 patients were at risk in the fifth year. The survival curve for patients with three-vessel disease also runs below that of the general public, but the curves converge at five years. In patients with two-vessel and onevessel disease the survival curves differ little from those of the general public. Fig. 4 shows that the survival curves for one-and two-vessel disease are slightly higher than those for three-vessel and left main disease. The only statistically significant differences between categories are the better survival of the patients with two-vessel disease as compared with three-vessel disease at one month and at two and three years.
As can be seen in Fig. 5 , age has an important effect on survival after coronary bypass surgery, but it accords with the effect of age on survival in general. No deaths were noted in patients under 40 years of age, but the numbers at risk in the fourth and fifth years were small. Patients in the fifth decade survived 1-5 per cent less well than the general public and patients in the sixth decade survived 1X3 per cent better than the general public. Neither difference is significant. Survival of the older patients equalled that of the general public. Fig. 6 shows that the survival curve for women runs consistently but not significantly below that of men. Table 4 and Fig. 7 show the relation of the survivals at five years to those of the general public according to sex. Though in the general population more women survived than men, this relation did not hold for the patients undergoing operation. The female subset is the one in which the survival of the age-matched sample of the US population comes nearest to lying outside the 95 per cent confidence interval. Fig. 8 and Table 4 show that in this series of patients whether or not angina was unstable had little effect on survival after operation for the first five years. In Table 4 one can also note that a history of a myocardial infarction or the presence of an ejection fraction above or below 0-5 had insignificant effects on survival for five years in this series. Patients with one to three grafts had a slightly but insignificantly better survival at five years than the US population or patients with four to seven grafts.
Further analysis of our series by breaking subgroups into more specific subcategories is frustrated by dwindling numbers and hence the lower reliability of the results. Table 4 shows that when threevessel disease is divided by sex, the difference in survival is negligible (0-4%). Fig. 9 shows what sort of analysis can be tried when more data and longer follow-up periods are available. In this figure the male cases are categorised as to age group and number of vessels involved, and the expected mortality at five years from life- Fig. 10 shows no significant differences for the three years they have been followed. Survival at three years was 95-3 per cent for those with less than 90 per cent narrowing of at least one vessel, 93-8 per cent for the group meeting the stricter criterion.
CAUSES OF DEATH
In the first 30 days after operation 19 patients died. Eight had myocardial infarction, three had congestive heart failure, and two died suddenly. There were three technical difficulties at operation: an air embolism, an uncontrollable haemorrhage, and a dissecting haematoma. Sepsis was the primary cause of death in one patient, and contributed to the death of three others primarily classified otherwise. Two patients died of causes not primarily caused by either coronary artery disease or bypass surgery: one of necrosis of a pituitary tumour and the other of myasthenia gravis. Thirty-one deaths occurred later in the period of observation, which ranged up to five years. Eight died of congestive heart failure, and five of recurrent myocardial infarction. Sepsis was the primary cause of death in four, and sudden death occurred in two. The cause of death could not be ascertained in five patients, and three had cancer, with primaries in the lung, oesophagus, and larynx. One death each was caused by cerebral thrombosis, dissecting haematoma, suicide, and ulcerative colitis. In summary the early deaths were related to or precipitated by the operation. Three-quarters of the late deaths were related to the operation or to the underlying arterial disease and its effect on the heart and one-quarter to unrelated disease.
Discussion
Evolution of our surgical technique for coronary bypass surgery can be divided into three phases. The first phase, from 1968 to 1973, involved normothermic perfusion, and the pump oxygenator was primed with heparinised blood. Myocardial protection was achieved through fibrillation perfusion with apical venting of the left ventricle, and the sutures were interrupted. The intemal mammary artery was used frequently. In the second period, from 1974 to 1975, a bloodless prime was used with moderate hypothermia of the blood from 280 to 30°C. Periodic defibrillation between distal anastomoses was carried out and a continuous suture technique was used. In the third phase, which began at the beginning of 1976 and has continued to the present time, cold cardioplegia was used followed by hyperkalaemic cardioplegia. We now use a combination of these techniques of cardioplegic myocardial protection, usually with the addition of methylprednisolone at high intracardiac concentration (approximately 1 mg/g cardiac tissue). A prospective randomised study carried out in 197626 showed the improved myocardial protection afforded by either cold cardioplegia or hyperkalaemic cardioplegia over the fibrillation perfusion.
Survival of the general population of the United States has been criticised as an inappropriate standard for comparison of the results of coronary bypass surgery. Surgical candidates are carefully screened to eliminate many acute and chronic diseases which contribute to the mortality of the general public. But as pointed out by Kirklin et al.7 the survival of the general population provides a less elastic standard against which to measure surgical results than medical treatment, with which many believe the results are also improving. 27 We have not found any reports of medical treatment of angiographically demonstrated multivessel coronary atherosclerosis with five-year survival equal to the general population.' The closest approach is the series of Kent et al.28 of mildly symptomatic and asymptomatic patients treated medically. They showed an annual mortality for two years of 2 4 per cent in patients with two-and three-vessel disease, compared with the annual mortality of 1-1 per cent for five years in our surgical series (775 patients with two-and three-vessel disease, most of whom had significant angina).
One can also question the use of the general population of the United States as a reference for our series which is largely from western New York State, and predominantly white. The survival of whites in western New York is not available with the same accuracy as that of the whole population, and the comparison is less reliable. We have therefore used data which are matched only for age and sex. If the 1051 patients are matched for age and sex with whites from the US population, the predicted five-year survival is 93 9 per cent instead of 93-6 per cent predicted on the basis of all races. In either case the 94 0 per cent five-year survival of the 1051 surgical patients equals the comparison group. We also compared all our subgroups with the US vital statistics for whites instead of for all races, and still found no differences which were significant at the 5 per cent level. Age appears to be the most important factor influencing long-term survival after surgery in our 1973-77 cohort and, though its effect appears to be non-specific, a trend in the data appears when one plots the influences of age and number of vessels involved on five-year attrition (100 minus per cent survival) for the men in our series as is seen in Fig. 9 that of an age-and sex-matched group of the US population, 904 per cent. Their series, from an earlier date and followed two years longer than ours, is similar to ours in reflecting no significant survival differences according to single, double, or triple bypass grafts, and slightly but not statistically significantly better survival of men than women. On the other hand, their differences in survival according to ejection fraction and presence of left main disease were more distinct than ours.
Conclusions
Life-table analysis of survival of our patients having coronary bypass surgery between 1973 and 1977 shows that estimated survival at five years is statistically indistinguishable from that of the US general population matched for age and sex. The same statement holds true when applied to subsets of our patients divided according to number of vessels critically narrowed, sex, age, number of segments grafted, history of myocardial infarctions, ejection fraction, or presence of unstable angina. Though the US population matched for age and sex is not an ideal control group for our surgical series it does serve as a reference point which is independently derived, and not so far equalled by medical management in any reported series of arteriographically diagnosed patients with multivessel disease. These findings provide additional support for the impressive mass of data now indicating that the best results in coronary artery disease come from surgical revascularisation supplemented by all applicable medical measures. They also permit the confident recommendation of coronary bypass surgery for many different subsets of patients based on its capacity to prolong life as well as to ameliorate symptoms. 
